CurrentCardio
Get Weekly

Topic · page 22 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 841–880 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. J Am Coll Cardiol

    Sex Differences in Dilated Cardiomyopathy: Evidence Gaps and Future Directions

    Meta-analysis

  2. J Am Coll Cardiol

    Trends in the Prevalence, Associated Risk Factors, and Health Burden of Heart Failure in the United States, 1988 to 2023

    Cross-sectional study

  3. Eur J Heart Fail

    Effects of Semaglutide in Obesity-Related Heart Failure with Preserved Ejection Fraction Across the Age Spectrum: Findings from the STEP-HFpEF Programme

    Secondary analysis

  4. JACC Heart Fail

    Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

    Cohort study

  5. JACC Heart Fail

    Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial

    Secondary analysis

  6. Europace

    Associations between cardiac resynchronization therapy and clinical outcomes according to the atrial fibrillation status in patients with heart failure with reduced ejection fraction

    Cohort study

  7. J Am Coll Cardiol

    Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy

    Secondary analysis

  8. Eur J Prev Cardiol

    Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study

    Cohort study

  9. Eur J Heart Fail

    Glucagon-Like Peptide-1 Receptor Agonists Reduce Atrial Fibrillation Among Patients with Heart Failure with Preserved and Mildly Reduced Ejection Fraction – a Meta-Analysis of Randomized Controlled Trials

    Meta-analysis

  10. Eur J Heart Fail

    Clinical Profiles and Prognostic Impact of Residual Intravascular and Tissue Congestion in Acute Heart Failure

    Secondary analysis

  11. Circulation

    Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

    Randomised controlled trial

  12. Circulation

    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

    Randomised controlled trial

  13. J Am Coll Cardiol

    Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials

    Randomised controlled trial

  14. J Am Coll Cardiol

    Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized Trial

    Randomised controlled trial

  15. Eur J Heart Fail

    Adherence to Guideline-Directed Medical Treatments in Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy

    Guideline or statement

  16. J Am Coll Cardiol

    Predicting Heart Failure From 12-Lead ECGs Using AI: A HeartShare/AMP-HF Pooled Cohort Analysis

    Cohort study

  17. J Am Coll Cardiol

    Myocardial Amyloid Burden in Transthyretin Amyloidosis

    Cohort study

  18. Europace

    Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy

    Cohort study

  19. JACC Heart Fail

    Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study

    Secondary analysis

  20. Eur J Prev Cardiol

    Risk of new-onset heart failure and heart failure exacerbations following COVID-19, influenza, or respiratory syncytial virus hospitalization

    Cohort study

  21. Eur J Heart Fail

    Finerenone in Patients with Severe Heart Failure: The FINEARTS-HF Trial

    Secondary analysis

  22. Eur J Heart Fail

    Short- and Mid-Term Effects of Empagliflozin on Sodium Balance and Fluid Regulation in Chronic Heart Failure

    Randomised controlled trial

  23. Eur J Heart Fail

    Urinary Markers in Heart Failure – Types, Timing and Thresholds. European Journal of Heart Failure Expert Consensus Document

    Guideline or statement

  24. Eur J Prev Cardiol

    Longitudinal trajectories of albuminuria and risk of subclinical and clinical heart failure, atrial fibrillation, and coronary heart disease: the MESA study

    Cohort study

  25. JAMA Cardiol

    Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related Cardiomyopathies

    Cohort study

  26. JACC Heart Fail

    Serum Magnesium and the Effect of Empagliflozin in Heart Failure With Reduced Ejection Fraction: Findings From EMPEROR-Reduced

    Secondary analysis

  27. JACC Heart Fail

    Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

    Randomised controlled trial

  28. J Am Coll Cardiol

    Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance

    Guideline or statement

  29. Eur J Heart Fail

    European Journal of Heart Failure Expert Consensus Statement on Transcatheter Treatment of Mitral Regurgitation in Heart Failure

    Guideline or statement

  30. Eur J Heart Fail

    Left Ventricular Transthyretin Amyloid Load and Apical Sparing in Patients with Newly Confirmed Transthyretin Amyloid Cardiomyopathy

    Cohort study

  31. JACC Heart Fail

    Diet and Clinical Outcomes in a Heart Failure Population

    Cohort study

  32. JACC Cardiovasc Imaging

    Fully Automatic AI-Based Quantification of LV Mass in Echocardiography: A Multimodality Validation

    Diagnostic or prognostic study

  33. Eur J Heart Fail

    Outpatient Loop Diuretic Use and the Effect of Natriuresis-Guided Diuretic Therapy: A Prespecified Sub-Analysis of the PUSH-AHF Study

    Secondary analysis

  34. J Am Coll Cardiol

    Tricuspid Regurgitation Across the Spectrum of Heart Failure With Preserved Ejection Fraction

    Cohort study

  35. Eur J Heart Fail

    Efficacy and Safety of Vutrisiran in Transthyretin Amyloid Cardiomyopathy Across the Age Spectrum: The HELIOS-B Trial

    Secondary analysis

  36. JACC Cardiovasc Interv

    Transcatheter Edge-to-Edge Repair for SAM-Related Mitral Regurgitation in Patients With HCM: The TRANSPARENT Registry

    Cohort study

  37. JACC Cardiovasc Imaging

    Improving the Diagnosis of HFpEF: A Comparison of the H2FPEF Score and the 2025 ASE Diastolic Function Guideline Recommendations Using Invasive Hemodynamics as the Gold Standard

    Diagnostic or prognostic study

  38. Eur J Heart Fail

    European Journal of Heart Failure Consensus Statement. Heart Failure Pharmacotherapy for Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Atrial Fibrillation: Review of Evidence and Call to Action

    Guideline or statement

  39. JACC Heart Fail

    Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes Registry

    Cohort study

  40. JACC Heart Fail

    Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF Trial

    Secondary analysis

All 1,928 Briefs in ExploreShowing Briefs 841–880 of 1,928, newest first